the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care.
Through an extensive lineup of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities, the Congress promotes important scientific discourse and advancement.
Werfen’s Booth #321 will, once again, showcase its Hemostasis portfolio, including the new ACL TOP Family 70 Series Testing Systems. Models on display will include: ACL TOP 370, ACL TOP 570, ACL TOP 770, ACL TOP 770 LAS, and ACL TOP 970 CL. HemoCell Specialized Lab Automation, connected to an ACL TOP 770 LAS, will be showcased (including a Virtual Reality experience).
Additionally, the ACL AcuStar, HemoHub Intelligent Data Manager and HemosIL Assays will be showcased. For the first time, the booth will include a large wall of our extensive HemosIL menu, as well as a large display case where a variety of reagents will be displayed.
Werfen’s Whole Blood Hemostasis systems, including ROTEM sigma, VerifyNow and GEM Hemochron 100, will also be on display, while videos promoting AccuTrak 2.0 and Werfen Academy will continuously play.
There will be two demonstration areas in the booth where registration is encouraged. This will help ensure an optimal experience for customers and prospects who are interested in learning more about our new ACL TOP Family 70 Series systems and/or participating in the HemoCell Virtual Reality experience.
Werfen will sponsor a Presentation Theater education session, entitled Bridging the Gap: Strategies for Transitioning Patients from DOACs to Unfractionated Heparin.
Our speaker for this event is Dr. Deepa J Arachchillage, Consultant Haematologist and Honorary Senior Lecturer, MRC CARP Fellow at Imperial College and Imperial College Healthcare in London, England. The event will be videotaped and added to Werfen Academy, for on-demand viewing.
EEMEA Hemostasis Team


